Reviews Dysport


No reviews yet.

Dysport Drug Description
DYSPORT™
(abobotulinumtoxinA) for Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of DYSPORT™ and all botulinum
toxin products may spread from the area of injection to produce symptoms consistent
with botulinum toxin effects. These may include asthenia, generalized muscle
weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria,
urinary incontinence and breathing difficulties. These symptoms have been reported
hours to weeks after injection. Swallowing and breathing difficulties can be
life threatening and there have been reports of death. The risk of symptoms
is probably greatest in children treated for spasticity but symptoms can also
occur in adults treated for spasticity and other conditions, particularly in
those patients who have underlying conditions that would predispose them to
these symptoms. In unapproved uses, including spasticity in children and adults,
and in approved indications, cases of spread of effect have been reported at
doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION
Botulinum toxin type A, the active ingredient in DYSPORT™ (abobotulinumtoxinA),
is a purifed neurotoxin type A complex produced by fermentation of the bacterium
Clostridium botulinumtype A, Hall Strain. It is purifed from the culture
supernatant by a series of precipitation, dialysis, and chromatography steps.
The neurotoxin complex is composed of the neurotoxin, hemagglutinin proteins
and non-toxin non-hemagglutinin protein.
DYSPORT™ is supplied in a single-use, sterile vial for reconstitution
intended for intramuscular injection. Each vial contains 500 or 300 Units of
lyophilized abobotulinumtoxinA, 125 micrograms human serum albumin and 2.5 mg
lactose. DYSPORT™ may contain trace amounts of cow's milk proteins [see
CONTRAINDICATIONS].
One unit of DYSPORT™ corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specifc to Ipsen's
product DYSPORT™ Due to differences in specifc details such as vehicle,
dilution scheme and laboratory protocols for various mouse LD50 assays, Units
of biological activity of DYSPORT™ are not interchangeable with Units
of any other botulinum toxin or any toxin assessed with any other specifc assay
method [see Dosage Forms and Strengths].
Last reviewed on RxList: 5/22/2009




Dysport Drug Description
DYSPORT™
(abobotulinumtoxinA) for Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of DYSPORT™ and all botulinum
toxin products may spread from the area of injection to produce symptoms consistent
with botulinum toxin effects. These may include asthenia, generalized muscle
weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria,
urinary incontinence and breathing difficulties. These symptoms have been reported
hours to weeks after injection. Swallowing and breathing difficulties can be
life threatening and there have been reports of death. The risk of symptoms
is probably greatest in children treated for spasticity but symptoms can also
occur in adults treated for spasticity and other conditions, particularly in
those patients who have underlying conditions that would predispose them to
these symptoms. In unapproved uses, including spasticity in children and adults,
and in approved indications, cases of spread of effect have been reported at
doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION
Botulinum toxin type A, the active ingredient in DYSPORT™ (abobotulinumtoxinA),
is a purifed neurotoxin type A complex produced by fermentation of the bacterium
Clostridium botulinumtype A, Hall Strain. It is purifed from the culture
supernatant by a series of precipitation, dialysis, and chromatography steps.
The neurotoxin complex is composed of the neurotoxin, hemagglutinin proteins
and non-toxin non-hemagglutinin protein.
DYSPORT™ is supplied in a single-use, sterile vial for reconstitution
intended for intramuscular injection. Each vial contains 500 or 300 Units of
lyophilized abobotulinumtoxinA, 125 micrograms human serum albumin and 2.5 mg
lactose. DYSPORT™ may contain trace amounts of cow's milk proteins [see
CONTRAINDICATIONS].
One unit of DYSPORT™ corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specifc to Ipsen's
product DYSPORT™ Due to differences in specifc details such as vehicle,
dilution scheme and laboratory protocols for various mouse LD50 assays, Units
of biological activity of DYSPORT™ are not interchangeable with Units
of any other botulinum toxin or any toxin assessed with any other specifc assay
method [see Dosage Forms and Strengths].
Last reviewed on RxList: 5/22/2009




Dysport Drug Description
DYSPORT™
(abobotulinumtoxinA) for Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of DYSPORT™ and all botulinum
toxin products may spread from the area of injection to produce symptoms consistent
with botulinum toxin effects. These may include asthenia, generalized muscle
weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria,
urinary incontinence and breathing difficulties. These symptoms have been reported
hours to weeks after injection. Swallowing and breathing difficulties can be
life threatening and there have been reports of death. The risk of symptoms
is probably greatest in children treated for spasticity but symptoms can also
occur in adults treated for spasticity and other conditions, particularly in
those patients who have underlying conditions that would predispose them to
these symptoms. In unapproved uses, including spasticity in children and adults,
and in approved indications, cases of spread of effect have been reported at
doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION
Botulinum toxin type A, the active ingredient in DYSPORT™ (abobotulinumtoxinA),
is a purifed neurotoxin type A complex produced by fermentation of the bacterium
Clostridium botulinumtype A, Hall Strain. It is purifed from the culture
supernatant by a series of precipitation, dialysis, and chromatography steps.
The neurotoxin complex is composed of the neurotoxin, hemagglutinin proteins
and non-toxin non-hemagglutinin protein.
DYSPORT™ is supplied in a single-use, sterile vial for reconstitution
intended for intramuscular injection. Each vial contains 500 or 300 Units of
lyophilized abobotulinumtoxinA, 125 micrograms human serum albumin and 2.5 mg
lactose. DYSPORT™ may contain trace amounts of cow's milk proteins [see
CONTRAINDICATIONS].
One unit of DYSPORT™ corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specifc to Ipsen's
product DYSPORT™ Due to differences in specifc details such as vehicle,
dilution scheme and laboratory protocols for various mouse LD50 assays, Units
of biological activity of DYSPORT™ are not interchangeable with Units
of any other botulinum toxin or any toxin assessed with any other specifc assay
method [see Dosage Forms and Strengths].
Last reviewed on RxList: 5/22/2009




Dysport Drug Description
DYSPORT™
(abobotulinumtoxinA) for Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of DYSPORT™ and all botulinum
toxin products may spread from the area of injection to produce symptoms consistent
with botulinum toxin effects. These may include asthenia, generalized muscle
weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria,
urinary incontinence and breathing difficulties. These symptoms have been reported
hours to weeks after injection. Swallowing and breathing difficulties can be
life threatening and there have been reports of death. The risk of symptoms
is probably greatest in children treated for spasticity but symptoms can also
occur in adults treated for spasticity and other conditions, particularly in
those patients who have underlying conditions that would predispose them to
these symptoms. In unapproved uses, including spasticity in children and adults,
and in approved indications, cases of spread of effect have been reported at
doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION
Botulinum toxin type A, the active ingredient in DYSPORT™ (abobotulinumtoxinA),
is a purifed neurotoxin type A complex produced by fermentation of the bacterium
Clostridium botulinumtype A, Hall Strain. It is purifed from the culture
supernatant by a series of precipitation, dialysis, and chromatography steps.
The neurotoxin complex is composed of the neurotoxin, hemagglutinin proteins
and non-toxin non-hemagglutinin protein.
DYSPORT™ is supplied in a single-use, sterile vial for reconstitution
intended for intramuscular injection. Each vial contains 500 or 300 Units of
lyophilized abobotulinumtoxinA, 125 micrograms human serum albumin and 2.5 mg
lactose. DYSPORT™ may contain trace amounts of cow's milk proteins [see
CONTRAINDICATIONS].
One unit of DYSPORT™ corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specifc to Ipsen's
product DYSPORT™ Due to differences in specifc details such as vehicle,
dilution scheme and laboratory protocols for various mouse LD50 assays, Units
of biological activity of DYSPORT™ are not interchangeable with Units
of any other botulinum toxin or any toxin assessed with any other specifc assay
method [see Dosage Forms and Strengths].
Last reviewed on RxList: 5/22/2009




Dysport Drug Description
DYSPORT™
(abobotulinumtoxinA) for Injection

Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of DYSPORT™ and all botulinum
toxin products may spread from the area of injection to produce symptoms consistent
with botulinum toxin effects. These may include asthenia, generalized muscle
weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria,
urinary incontinence and breathing difficulties. These symptoms have been reported
hours to weeks after injection. Swallowing and breathing difficulties can be
life threatening and there have been reports of death. The risk of symptoms
is probably greatest in children treated for spasticity but symptoms can also
occur in adults treated for spasticity and other conditions, particularly in
those patients who have underlying conditions that would predispose them to
these symptoms. In unapproved uses, including spasticity in children and adults,
and in approved indications, cases of spread of effect have been reported at
doses comparable to those used to treat cervical dystonia and at lower doses.

DRUG DESCRIPTION
Botulinum toxin type A, the active ingredient in DYSPORT™ (abobotulinumtoxinA),
is a purifed neurotoxin type A complex produced by fermentation of the bacterium
Clostridium botulinumtype A, Hall Strain. It is purifed from the culture
supernatant by a series of precipitation, dialysis, and chromatography steps.
The neurotoxin complex is composed of the neurotoxin, hemagglutinin proteins
and non-toxin non-hemagglutinin protein.
DYSPORT™ is supplied in a single-use, sterile vial for reconstitution
intended for intramuscular injection. Each vial contains 500 or 300 Units of
lyophilized abobotulinumtoxinA, 125 micrograms human serum albumin and 2.5 mg
lactose. DYSPORT™ may contain trace amounts of cow's milk proteins [see
CONTRAINDICATIONS].
One unit of DYSPORT™ corresponds to the calculated median lethal intraperitoneal
dose (LD50) in mice. The method for performing the assay is specifc to Ipsen's
product DYSPORT™ Due to differences in specifc details such as vehicle,
dilution scheme and laboratory protocols for various mouse LD50 assays, Units
of biological activity of DYSPORT™ are not interchangeable with Units
of any other botulinum toxin or any toxin assessed with any other specifc assay
method [see Dosage Forms and Strengths].
Last reviewed on RxList: 5/22/2009





Other reviews about Dysport on wordpress

FDA Approves Dysport for Wrinkle Removal
  by Cosmetic Surgery Review
If you’ve been thinking about getting Botox to get rid of wrinkles around the eyes and freshening up your look, there may soon be another option.  Drugs such […]


Benefits of Dysport over Botox...
  by dysport
Ok... so why should i get Dysport over Botox? Even though there are very minor differences between Dysport and Botox, there is enough to make one decide that Dysport […]


Dysport... The New Botox Competitor!
  by dysport
Dysport received FDA approval this past April. Botox was the only treatment available, previous to Dysport's approval, that gave the immediate, simple and affordable wrinkle and frown line […]


The Launch of Dysport
  by Davis
Eileen Slutsky, RN, BSN was recently invited to the Medicis Speaker Program in Chicago as a National Top Injector.  The 3-day training and launch of Dysport (a competitor […]


Dysport or Botox?
  by hairdoc
Q: I was surfing the Web and came across some content about Dysport. They said it is a new version of Botox, but it is a bit cheaper. I'm […]


Meg's Make up comes to DC, let's Party!
  by Dr. Dima
 Location: 1801 Robert Fulton Drive Suite 540 Reston, VA 20191     Date: Thursday March 4th 2010     Time: 7:00 p.m. Items to be raffled include: Botox Treatment Latisse Kit Body Treatments Dysport Treatment And MORE! CALL 703.787.9866 TO […]


Take the Dysport Challenge!!
  by robin37e
  Everybody's talking about Dysport, a prescription injection used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 […]


Why Patients Should Try Dysport Injectable Instead of Botox
  by drstevegoldman
A new alternative to Botox, Dysport injectable is taking the industry by storm and Cleveland plastic surgeon, Dr. Goldman has jumped on the bandwagon. Dr. Goldman […]


Considering Injectible Procedures? Cosmetic Surgeon Dr. Goldman Can Help You!
  by drstevegoldman
You're Invited to Our Day of Injectables Event in April Have you ever considered having injectable treatments such as Juvederm or Dysport? Are you already receiving such treatments but would […]


What can Dysport do for you?
  by Dr. Dima
What can Dysport do for you? Whenever you laugh, frown, concentrate or squint into the sun, your facial muscles contract and your skin creases. As you get older your […]



Other reviews about Dysport on web:

DYSPORT™ (abobotulinumtoxinA for Injection) Welcome to Dysport.com. Get important information about the indications, use, and history of Dysport. Learn more about Dysport


Dysport is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years ... Dysport :: Home


Individual results may vary. Discuss your situation with your specialist. Dysport® - Take a fresh look at wrinkle treatment. Appearance ...


70+ Dysport Reviews with Cost, Side Effects, Before & After Photos. Get Free Doctor Tips on Dysport vs. Botox for Wrinkle Treatment. Dysport: Worth It? Reviews, Side Effects, Cost, Before and After


Dysport treatments in Washington, DC. Offers Dysport brand of botolinum toxin, a competitor to Botox injections. Also previously marketed as Reloxin. Serving Maryland, Northern ... Dysport Treatments (Reloxin) - Washington, D.C. Dysport at The ...


Learn about Dysport and its approved uses. See how it compares with Botox, its potential complications and cost. Dysport Injections - are they better than Botox? - Cost & Results


Receive treatment with Dysport by September 30, 2010; Within 30 days of your treatment: 1) Visit this website; 2) Register First


Accurate, FDA approved Dysport information for healthcare professionals and patients - brought to you by Drugs.com. Dysport Official FDA information, side effects and uses.


Dysport (abobotulinumtoxinA) is used to treat cervical dystonia and glabellar lines. Includes Dysport side effects, interactions and indications. Dysport Information from Drugs.com


Dysport is the newest injectable in the U.S. market treating deep lines and wrinkles. Some say it may be a better, cheaper choice, especially if Botox doesn't work for you anymore Dysport - Using Dysport Vs. Botox





Featured Reviews

Reviews Dorzolamide Hydrochloride Ophthalmic Solution

Trusopt Drug Description TRUSOPT® (dorzolamide hydrochloride) Sterile Ophthalmic Solution 2% DRUG DESCRIPTION What are the possible side effects of dorzolamide ophthalmic (Trusopt)? Get emergency medical help if you have any...
Read More  |  Review This
Reviews Clotrimazole

Mycelex Drug Description MYCELEX® (clotrimazole) TROCHE FOR TOPICAL ORAL ADMINISTRATION DRUG DESCRIPTION What are the possible side effects of clotrimazole (Mycelex Troche)? Stop taking clotrimazole and seek emergency medical...
Read More  |  Review This
Reviews Epoetin Alfa

Procrit Drug Description PROCRIT® (epoetin alfa) For Injection WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED RISK OF TUMOR PROGRESSION OR RECURRENCE Chronic Renal Failure: ...
Read More  |  Review This
Reviews Aminohippurate Sodium

Aminohippurate Sodium Drug Description Aminohippurate Sodium* "PAH" Injection DRUG DESCRIPTION Aminohippurate sodium is an agent to measure effective renal plasma flow (ERPF). It is the sodium salt of para-aminohippuric acid, commonly...
Read More  |  Review This
Reviews Armour Thyroid

Armour Thyroid Drug Description Armour® Thyroid (thyroid) Tablets, USP DRUG DESCRIPTION What are the possible side effects of thyroid (Armour Thyroid, Westhroid)? If you experience any of the following uncommon but serious...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....